MT

Mercedes Tuin

Venture Capital in Life Sciences and MedTech

Bussum, North Holland

Invests in

Stages:

Sectors:

Health & Hospital Services

Locations:

Min Investment:
$100,000.00
Max Investment:
$5,000,000.00
Target Investment:
$1,500,000.00

Skills

Education

MBA
Rotterdam School of Management, Erasmus University
(2009 - 2010)
MSc
Vrije Universiteit Amsterdam (VU Amsterdam)
(2003 - 2005)

Investments

RiboPro

Total Funding: $1M

Work Experience

Brabantse Ontwikkelings Maatschappij (BOM)

2018

Investment Director Life Sciences & MedTech
2023
With a team of 6 people we invest in start-ups and scale-ups developing innovative therapeutics, diagnostics, medical devices and healthcare solutions.
Sr Investment Manager Life Sciences-MedTech & Strategy Theme lead Healthy Future
2019 - 2023
BOM Brabant Ventures is a Venture Capital investor realising impact in Noord Brabant enabling start-ups and scale-ups to grow. De BOM investeert in schaalbare start- en scale ups met groeipotentie en een sterke link met Noord-Brabant. BOM Brabant Ventures portfolio includes Acerta Pharma, Atro Medical, BioConnection, BioNovion (Aduro), Cytomate, Cytura, DegenRx, Glycostem, RiboPro, , IME Technologies, Innatoss, InProcessLSP, Lead Pharma, Cristal Therapeutics, Medeye, NTRC, Preceyes, Salvia, SamanTree Medicsl, Synaffix, Ventinova and DegenRx.
Investment Manager Life Sciences & Medtech
2018 - 2019

2021

Board
2021

SamanTree Medical SA

2019

Board
2019

2018

Board
2018

2021 - 2024

Board
2021 - 2024

2021 - 2023

Board
2021 - 2023

2020 - 2023

Board
2020 - 2023

2018 - 2023

Board
2018 - 2023

AMC - Innovation Exchange Amsterdam (IXA) - Pontes Medical - Pontes IMPACT

2010 - 2018

Business Developer - Innovation Manager -Project leader IMPACT Health
2010 - 2018

Drug Discovery Factory

2008 - 2010

Business Development Manager
2008 - 2010